Washington, July 28 -- Representative Emanuel Cleaver issued the following press release:
Today, U.S. Representative Emanuel Cleaver, II (D-MO) released the following statement after his bipartisan amendment to provide $5 million for alpha-gal syndrome research was included in the underlying text of the Fiscal Year 2027 National Defense Authorization Act (NDAA).
"Today marks an important step forward for the hundreds of thousands of Americans living with alpha-gal syndrome. By including my bipartisan amendment to invest $5 million in dedicated research, Congress is finally beginning to address a growing health challenge that has gone underrecognized and underfunded for far too long.
"For too many families, an alpha-gal diagnosis has mean...